Изберете език

bg
  • bg

  • cs

  • da

  • de

  • el

  • en

  • es

  • et

  • fr

  • hr

  • hu

  • it

  • lt

  • lv

  • nl

  • no

  • pl

  • pt

  • ro

  • ru

  • sk

  • sl

  • sv

  • tr

  • uk

Български
  • Български

  • Čeština

  • Danske

  • Deutsch

  • ελληνική

  • English

  • Español

  • Eesti keel

  • Français

  • Hrvatski

  • Magyar

  • Italiano

  • Lietuvių

  • Latviešu

  • Nederlands

  • Norsk

  • Polski

  • Português

  • Română

  • Русский

  • Slovenský

  • Slovenski

  • Svenska

  • Türkçe

  • Українська

Как предпочитате да зареждате своята сметка?

* Не начисляваме комисионна за депозиране на средства във вашата сметка

Gilead Sciences

GILD.US $ 67.7 USD

-0.26 $ (-0.39%)

Потенциал за растеж

10.1%

Доход от дивиденти

3.49%

1d
1w
1 мес.
6 м.
През цялото време

Добавяне в количката

1 лот = 1 акция

Закупено количество:

Брокерска комисионна:

Комисионна за прехвърляне:

Препоръка

Strong Buy

Рейтинг за ефективност

DCF

73.26

ROE

0.01

ROA

-

P/S

3.34

P/B

4.53

Debt / Equity

1.57

Относно компанията

Gilead Sciences is the largest American biopharmaceutical company engaged in research and development of healthcare products and has a batch production of innovative medicines. The Company was founded in 1987 by a 29-year-old doctor Michael L. Riordan. Gilead's technologies, as well as the drugs themselves, have established themselves as a leading choice when it comes to prevention and cure of the most fatal human diseases. The Company's main efforts have been focused on HIV cure development as well as various treatments of chronic hepatitis B and C, cancers, cardiovascular and respiratory diseases. Among the well-known products are Tamiflu, Atripla, Vistide, Emtriva. The latest successful project of Gilead was Sovaldi, which is an effective medicine for hepatitis C cure. The innovation has become an all-time record of sales. The company's research centers are located in the American cities of Boulder and San Dimas. The company has a rather small staff number, which is about 8,000 employees, with a fairly large turnover of almost $ 25 billion. Today Gilead Sciences boasts of being one of the most speedily developing start-ups in its field. Its headquarters are in California, though the company has its representative offices in other states of North America, as well as in Europe, Asia, and Australia.


Регистрирайте се за инвестиционни идеи от анализаторите на Freedom Finance

Веднъж седмично ще изпращаме имейл само с най-подходящата и важна информация

Поздравления!

Сега винаги ще знаете кои акции са по-доходоносни за инвестиция